Specifica Announces Antibody Discovery PlatformTransfer Agreement with Servier and its Subsidiary Symphogen SANTA FE, N.M. – 17th March 2023 – Specifica, a Q2 Solutions company focused on innovative in vitro antibody libraries…

SANTA FE, N.M.--(BUSINESS WIRE)--Specifica, a privately held antibody engineering company focused on innovative in vitro antibody libraries and discovery tools, today announced an agreement with the global healthcare company Sanofi under…

SANTA FE, NM – (BUSINESS WIRE) – Mar. 10, 2022 – Specifica, a privately held antibody engineering company focused on innovative in vitro antibody library and discovery tools, announced the…

SANTA FE, NM – (BUSINESS WIRE) – Jan. 24, 2022 – Specifica, a privately held antibody engineering company focused on innovative in vitro antibody library and discovery tools, announced the…

Next Generation Sequencing Software to Help Antibody Engineers, Bioinformaticians Uncover Potential Antibody Therapeutics SANTA FE, N.M. – December 2, 2021 – OpenEye Scientific and Specifica, Inc., today announced they are…

Santa Fe, New Mexico, December 1, 2020 — Specifica, a company revolutionizing antibody discovery, today announced that it has delivered an exclusive antibody library platform to UCB, a global biopharmaceutical…

Santa Fe, New Mexico, August 5, 2020 — Specifica, a company revolutionizing antibody discovery, today announced that it has designed and created an exclusive antibody display library in collaboration with…